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Age < 65 Age> 65
Patients Controls Patients Controls
Homocysteine 12.2 ± 4.0' 11.0 ± 3.4 14.2 ± 4.6' 11.9 ± 3.6
High HCY(%) 33' 20 50t 25
Odds Ratios 2.0' NA 2.9' NA
Confidence Interval 12-3.2 NA lQ-8.3 NA
Ciradian Variation of Silent Myocardial Ischemia
is Abolished by Propranolol
Relationship Between Homocyst(e)ine, Vitamin
B12 and Cardiac Disease in the Elderly
Barry C. Herzlich, Martin Weinstock, Edgar Lichstein, Nancy Schulhoff, M.
Rene Malinow. Maimonides Medical Center, State University of New York Health
Science Center at Brooklyn, NY; Oregon Regional Primate Research Center, Beaverton,
OR
[ 1015-731
Elevated plasma homocyst(e)ine (HCS) is an independent risk factor for coro-
nary artery disease (CAD) among middle aged adults. Moveover, HCS also in-
creases with age. This study assessed plasma HCS among 384 elderly (ages
73 ± 7 y) patients undergoing coronary angiography. The degree of CAD was
scored using proximal and diffuse (Freisenger) indices. Plasma HCS, serum
Vitamin B12 and folate and left ventricular ejection fraction (LVEF) were mea-
sured and risk factors for CAD were recorded. There was no apparent corre-
lation between plasma HCS and extent of CAD after adjusting for age. Nine
percent of patients (pts) had Vitamin B12 deficiency (B12 def), ie. Vitamin
B12. < 300 pg/ml as well as HCS > 16 nmol/ml. LVEF for the 32 B12 def
pts ~ 40.5% was significantly less than for 326 non B12 def pts with LVEF
= 50.6% (p < 0.001). Significance remained after adjusting for proximal and
Freisenger indices, history of smoking, diabetes, previous myocardial infarc-
tion, age and sex. (Adjusted Difference of LVEF ~ 8.2, 95% CI 2.6-13.8).
In conclusion we did not find a significant correlation between plasma HCS
and extent of CAD as assessed angiographically using proximal and diffuse
indices. The data demonstrate that B12 def pts (with elevated HCS levels)
had significantly lower LVEF than non B12 def pts. Whether low LVEF results
in malabsorption of Vitamin B12 and B12 def or, conversely, whether B12
def and its marker, ie, elevated HCS, depress LVEF, warrants further investi-
gation.
Wilbert S. Aronow, Chul Ahn, Anthony D. Mercando, Stanley Epstein. Hebrew
Hospital Home and Mount Sinai School ofMedicine, New York, NY
A prospective study investigated whether there is a circadian variation of
silent ischemia (SI) in elderly patients (pts) with heart disease before and after
propranolol and no antiarrhythmic (AA) drug. Follow-up 24-hour ambulatory
electrocardiograms were obtained at a median of 6 months (range 2 to 12)
in 221 elderly pts, mean age 81 ± 8 years, with heart disease (64% with prior
myocardial infarction and 36% with hypertensive heart disease) and complex
ventricular arrhythmias randomized to propranolol 85 ± 28 mg daily(112 pts)
or to no AA drug (109 ptsj. SI was diagnosed if horizontal or downsloping ST-
segment depression::: 1.0 mm below the level at rest occurred after the J
point, lasted::: 1.0 minute, and was unassociated with angina. If ST-segment
depression at rest occurred, an additional 2.0 mm of ischemic ST-segment
depression below the level at rest at 80 ms after the J point was needed. 51
was present before no AA drug in 35 of 109 pts (32%) and after no AA drug
in 39 of 109 pts (36%1 (p not significant). SI was present before propranolol
in 42 of 112 pts (38%) and after propranolol in 27 of 112 pts (24%) (p <
0.001). Double harmonic regression models showed a significant circadian
variation of the maximal amount of 51 before no AA drug (p = 0.002, R2 ~
58%, adjusted R2 = 49%). after no AA drug (p = 0.009, R2 = 50%, adjusted
R2 = 39%), before propranolol (p = 0.003, R2 = 56%, adjusted R2 = 46%1.
Methods: We studied 228 patients with angiographically documented
coronary disease (:::70% stenosis in at least one major epicardial vessel).
These included 136 patients less than, and 92 greater than 65 years old. Pa-
tients were compared to 223 healthy controls 199 «65) and 24 (>65). The
presence of traditional risk factors including hypertension, smoking, hyper-
cholesterolemia and diabetes mellitus were noted. Total fasting plasma ho-
mocysteine was measured in all subjects. A gender-adjusted threshold for a
high homocysteine level was defined as the 80th percentile for healthy con-
trols (corresponding to a level of 11.7 IlmollL in women and 13.61lmo1lL in
men).
Results:
'p< am vs controls, t p < 0.03
Conclusions: Homocysteine concentrations are elevated in patients with
coronary artery disease older than 65 years in age. A high value confers an in-
dependent three-fold risk for coronary disease in this patient group. Accord-
ingly, intervention studies designed to reduce plasma homocysteine levels
should not exclude the elderly.
11015-741
Lower Adenosine Levels During Early Ischemia:
Cause of Increased Injury in the Aging Heart?
Kishin Ramani, W. David Lust. Tim S. Whittingham, Edward J. Lesnefsky. Case
Western Reserve University. Cleveland, OH
Pre- Ischemia
ischemia 2 min 5min 10min 15 min 25 min
(n = 5) In ~ 51 tn = 6) (n = 6) (n ~ 5) tn ~ 5)
ADO 6mo 0.2 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 2.2 ± 0.2 37 ± 0.6 4.5 ± 0.3
24 mo 0.2 ± 0.1 05 ± 0.1 0.3 ± 0.1' 1.1 ± 0.3' 2.1 ± 0.3' 3.5 ± 04
HX 6mo 2.0 ± 0.2 1.6 ± 0.2 2.3 ± 03 2.2 ± 01 25 ± 0.2 2.8 ± 02
24mo 1.9 ± 0.2 1.4 ± 0.1 1.4 ± 02' 2.1 ± 0.2 2.2 ± 0.8 3.5 ± 03
(Mean ± SE, nmol/mg protein). 'p < 0.05 vs 6 mo
Myocardial injury following ischemia and reperfusion is increased in the ag-
ing heart, including in the aging 24 mo Fischer 344 rat (mean survival 29 mol
compared to the Fischer 344 adult (6 mo). Adenosine (ADO) has been in-
creasingly appreciated as a cardioprotective agent in myocardial ischemia.
We hypothesized that a potential mechanism of the increased injury in the
aging heart is decreased production of ADO in response to ischemia. Iso-
lated buffer perfused (glucose 5 mM - insulin 5 Ilfl) hearts from aging and
adult Fischer 344 rats were subjected to stop-flow ischemia for either 2, 5,
10, 15 or 25 min after a 15 min equilibration phase. ADO and hypoxanthine
(HX) were measured by HPLC Tissue total adenylates, ATP. glycogen and
lactate were measured.
available regarding the prognostic importance of SI in the elderly. Therefore,
we prospectively evaluated the prognostic significance of SI during Holter
monitoring (HM) in elderly pts (:::65 years) with stable angina and proved
CAD. The findings were then compared to those observed in a similar but
younger «65 yrs age) group of pts with stable CAD. All pts underwent max-
imal exercise treadmill test (ED) and HM for 24--48 hours, while receiving
their usual antianginal drugs. Pts were followed every 3 months and all fatal
and nonfatal events were recorded. The study population consisted of two
groups: pts < 65 (Gr 11 and pts ::: 65 (Gr 2) years old. The two groups were
similar in their clinical characteristics, risk factors for CAD, antianginal drugs,
and angiographic findings. Compared to Gr 1, the Gr 2 pts had a significantly
earlier onset of ischemia (p < 0.01) and achieved a significantly greater peak
systolic blood pressure (p < 0.02) during ED. Kaplan-Meier survival analy-
sis revealed a significant difference in the outcome of the two groups. The
Gr 1 pts with SI during HM had a nonsignificant increase in mortality (2/16,
12.5% vs. 1/19, 5.3%) compared to pts without SI. In contrast, elderly (Gr
2) pts with SI during HM had an eightfold increase in the risk of cardiac
death (7/23, 30.4% mortality vs. 1/28,3.6%, P = 0.009) compared to elderly
pts without SI. Multivariate Cox regression analysis of clinical variables, an-
giographic findings, ED parameters, and ischemia during HM, revealed the
presence of SI on HM as the most powerful and independent predictor (p ~
0.006) of cardiac death in the elderly.
Conclusion: The findings of our study clearly demonstrated that in the el-
derly pts, silent ischemia during daily life is associated with poor progno-
sis and a significantly increased risk of cardiac death. The adverse outcome
associated with SI was noted despite antianginal drug therapy effective in
controlling symptoms suggesting the need for more aggressive therapeutic
interventions.
ADO levels were 50% lower in the aging heart at 5 and 10 min, remained
depressed at 15 min and had not fully equalized to adult levels by 25 min
of ischemia. HX was decreased at 5 min, consistent with decreased ADO
production at that time. The change in total adenylate pool was similar in
both groups. The decrease in tissue glycogen and increase in lactate were
similar during ischemia in both groups, suggesting comparable glycolytic
activity. ATP levels were decreased in aging hearts at 5 min (11.1 ± 2.3 vs
18.7 ± 1.9 nmol/mg protein). but reached levels similar to adult hearts as
ischemia progressed.
Thus, decreased ADO levels during early ischemia may reflect reduced
production of ADO in the aging heart, and increase the susceptibility of the
aging heart to damage during ischemia and reperfusion.
Background: High plasma homocysteine (HCYj concentration is an estab-
lished risk factor for premature vascular disease which can be reduced using
vitamin therapy. The role of increased homocysteine as a coronary risk factor
in the elderly, however, remains uncertain.
Elevated Plasma Homocysteine: An Important
Independent Risk Factor for Coronary Artery
Disease in the Elderly
Ellen Mayer, AnJun Gupta, Dave P. Miller, Steven E. Nissen. Donald W. Jacobsen.
Ralph Green, Kindice Kottke Marchant, Killian Robinson. The Cleveland Clinic
Foundation, Cleveland, Ohio
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but not after propranolol (p = 0.715, R2 = 10%, adjusted R2 = 0%). The
primary peak incidence of the maximal amount of SI occurred between 8
a.m. and 9 a.m. before no AA drug, between 8 a.m. and 10 a.m. after no
AA drug, and between 8 a.m. and 11 a.m. before propranolol. There was no
secondary peak. These data show that there is a circadian variation of the
maximal amount of SI in elderly pts with heart disease which is abolished by
propranolol.
Yoshihisa Matsumura, Toshikazu Yabe, Hiroaki Kitaoka, Takashi Furuno,
Fumiyasu Yamasaki, Jun Takata, Taishiro Chikamori, Yoshinori Doi. Kochi Medical
School, Kochi, Japan
Atherosclerotic aortic plaques detected by transesophageal echocardiogra-
phy (TEE) have been reported to be a marker for coronary artery disease
(CAD). Its significance may particularly be important in elderly population,
though there are no data yet available. To elucidate the significance of aortic
plaques in the elderly, we performed TEE on 84 patients (pts) (44 men, 40
women, age 61 ± 11 years) who had previously undergone coronary arteri-
ography.
Results: (1) Significant CAD (~75% stenosis) was detected in at least one
major coronary artery in 26 of the 84 pts. Aortic plaques were detected by
TEE in 24 of the 26 pts with CAD (92%) and in 32 of 58 pts without CAD
(55%) (p < 0.01). (2) In pts aged ~70 years (n = 25), aortic plaques were
present in 13 of 14 pts with CAD (93%) and 10 of 11 pts without CAD (91 %)
(p = ns). In pts aged <70 years In = 59), aortic plaques were present in 10
of 12 pts with CAD (83%) and 22 of 47 pts without CAD (47%) (p = 0.02). (3)
The independent association between CAD and age, the presence of aortic
plaques on TEE and other coronary risk factors was examined by multiple
regression analysis. In pts aged ~70 years, the presence of aortic plaques
on TEE failed to be a predictor of significant CAD, although it was indeed a
strong predictor of CAD in pts aged <70 years (p < 0.01).
Conclusion: In elderly pts, atherosclerotic aortic plaque detected by trans-
esophageal echocardiography is not useful in predicting significant coronary
artery disease. It is useful only in a relatively younger population.
Real-Time Acoustic Assessment of Mechanical
Heart Valves
erates in the region of optimal coupling; during stress, changes in the state
of coupling result in additional contribution to CVS performance; in patients
with left ventricular dysfunction the efficiency is reduced and it further de-
creases during exercise. The model shows that there is, however, an optimal
coupling which improves performance even in cases of severe heart failure.
This optimal state can theoretically be approached by titrating the vascu-
lar resistance and the end-diastolic volume (the preload) to optimal levels.
These results suggest, and lay the theoretical foundation for the notion, that
vasodilator drugs can be used to optimize VA-coupling and CVS performance
in heart failure patients.
Reliable assessment of mechanical heart valve function remains a difficult
clinical problem. We have shown that 1) leaflets of bileaflet mechanical
valves do not close simultaneously and 2) the dominant energy contained
in closing sounds created by these valves is in the ultrasonic range (>20
kHz). Taking advantage of these findings, we designed a real-time Macintosh-
based system that permits a clinician to evaluate dynamic characteristics
of these valves by listening to closing sounds played back at slow speeds.
Valve sounds detected by a high-frequency accelerometer microphone are
amplified and undergo a 12-bit analog-to-digital conversion at 140 kHz. Dur-
ing data acquisition closing valve sounds are digitally detected for immedi-
ate playback through an audio output. The user can select the speed and
length of sound playback. While the expanded closing sounds are plotted
on the screen, the audio output gives the clinician a unique appreciation
of closing valve dynamics. Sound output can be through either a dedicated
digital-to-analog converter or the regular Macintosh sound interface, thus al-
lOWing previously recorded data to be presented on any standard Macintosh
system. A recording obtained from a patient with a bileaflet mitral valve is
shown below.8 MC
1sec
Richard L. Donnerstein. University ofArizona, Tucson, AZ
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Detection of Aortic Plaques is not Predictive of
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Institute of Technology, Haifa, Israel
Mathematical model and numerical simulation are used to analyze optimal
conditions of cardiovascular performance, with an emphasis on the effect
of ventricular-arterial (VA) coupling. The following research questions were
posed: Does the VA-coupling affect the cardiovascular system (CVS) perfor-
mance in addition to the direct effects of the left ventricle and of the vascular
load? Is there an optimal coupling state? Does the CVS in human subjects,
either healthy or diseased. operate with optimal VA-coupling? and finally, is
it possible to improve the CVS performance by controlling the VA-coupling?
To answer these questions. a clinically oriented integral model of the CVS
is introduced, based on the ventricular and arterial elastances. The main ad-
vantages of the model are its simplicity and the fact that all its variables can
be measured non-invasively in the clinical practice. Traditionally, the optimal
state of CVS operation was evaluated by two criteria - the energetic effi-
ciencyof the left ventricle and the efficiency of energy transfer through the
vascular system. In the present study a combined criterion of the total en-
ergetic efficiency is utilized - from the input metabolic energy consumed
by the ventricle to the net energy available to the peripheral tissues. It is
found that optimal coupling for maximal global efficiency depends in a com-
plex, non-linear way on all the classical determinants of CVS performance
- the preload, the myocardial contractility, the afterload and the heart rate.
Response surfaces of the analyzed variables as function of two independent
variables were generated by numerical simulation. Based on the analysis of
the global efficiency as the optimization criterion, answers to the research
questions were found: The VA-coupling affects the CVS performance in ad-
dition to the direct effects of its determinants; there is an optimal state of
coupling which results in maximal efficiency; the CVS in healthy subject op-
An Inexpensive, Easy to Use and Highly Portable
Quantitative Angiographic System
Slowing playback speed reduces dominant frequencies of valve closure
sounds into the audible range making it easy to recognize sounds from indi-
vidual leaflet impacts as well as noises caused by leaflets scraping against
valve structures. This system is directly applicable to sounds created by any
type of mechanical heart valve.
Conclusions: Slow speed playback of high-frequency sounds created by
closing mechanical heart valves gives important insight into valve function.
This technique, readily implemented with personal computers, provides a
simple and inexpensive method to screen patients with mechanical heart
valves.
Adnan Kastrati, Merita Shehu, Rudolf Blasini 1, Albert Schomig 1. 2nd Division of
Cardiology, Univ. Hosp. Center Tirana, Albania; 1 I. Med KJinik TU Milnchen, Germany
Ouantitative angiography is considered the "gold standard" for the assess-
ment of coronary arterial dimensions. The presence in the actual systems of
one or more disadvantages such as high cost, difficulty in usage and poor
portability, have prevented the wide utilization of this method. To implement
a similar system, the acquisition of the computer, software, digitizing board
and cineprojector with CCD camera is usually required. We developed a sys-
tem running on every Macintosh computer with only one special require-
ment, that of a commercially available slide scanner. A public domain soft-
ware, NIH Image (written by Wayne Rasband) was modified and expanded to
perform the following taskS: acquisition and storage of the digitized angio-
graphic frames, automatic edge detection and measurements, and saving
of the results in a text format file, readable from every database, spread-
sheet or statistical package. Films (courtesy of Dr. PatriCk W. Serruys, Rot-
terdam) of coronary phantoms with known size (05, 0.7, 1.0, 1.4, 1.9 mm)
implanted in pigs, were used for system validation. The angiographic frames
(24 x 18 mm) were digitized with a spatial resolution of 1850 pixels/inch (slide
scanners with higher resolution are also available) and 256 gray levels. Using
isocenter calibration, the measurements resulted in a correlation coefficient
of 096 (y = 0.86x + 0.12), accuracy of -0.03 mm and precision of 0.15 mm.
A correlation coefficient of 0.92 (y = 0.67x + 0.33), an accuracy of -0.03 mm
and a precision of 0.23 mm were found using catheter calibration. With the
same phantoms, the mean reproducibility was 0.08 mm for the interpolated
reference diameter (RD), 0.03 mm for the minimal luminal diameter (MLD),
1.4% for the diameter stenosis (OS) and 0.6 mm for the lesion length. The
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From Myocardial O2 Consumption to Mean
Arterial Power - Analysis of Optimal
Cardiovascular Performance
Cardiac Performance and Imaging
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